search

Cardlytics Inc (CDLX)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
Cardlytics (NASDAQ: CDLX) Resolves Amit Jain Indemnification Dispute with $6.4M Settlement
Sep 12, 2026

Cardlytics (NASDAQ: CDLX) Resolves Amit Jain Indemnification Dispute with $6.4M Settlement

Cardlytics (NASDAQ: CDLX) has settled an indemnification dispute with former Bridg CEO Amit Jain for $6.4 million. This settlement resolves claims related to the DailyGobble litigation and associated insurance proceedings, with Cardlytics assuming control of the Scottsdale insurance actions. The agreement fixes the payment amount while allowing for ongoing legal fee advances and insurance reimbursement efforts.
Company relevance
100.00%
Company sentiment
Somewhat-Bullish
Overall sentiment
Somewhat-Bullish